CPC C07C 271/12 (2013.01) [A61K 9/0053 (2013.01); A61K 31/165 (2013.01); A61K 31/27 (2013.01)] | 10 Claims |
1. A method of treating a sleep-wake disorder in a subject, comprising administration, to a subject in need of such treatment, of a therapeutically effective amount of a compound of the Formula (I):
![]() or a pharmaceutically acceptable salt or ester thereof wherein R, R1, R2 are hydrogen and x=1, and
wherein the cause of the sleep-wake disorder is chosen from the group consisting of stroke, narcolepsy, idiopathic CNS hypersomnia, sleep deficiency, sleep apnea, obstructive sleep apnea, insufficient nocturnal sleep, chronic pain, acute pain, Parkinson's disease, urinary incontinence, multiple sclerosis fatigue, Attention Deficit Hyperactivity Disorder (ADHD), Alzheimer's disorder, cardiac ischemia, misalignments of the body's circadian pacemaker with the environment, jet lag, shift work, and sedating drugs.
|